Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanezumab for pain due to bone metastases
NCT00545129Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2009
- Primary completion
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 2 trial of tanezumab in cancer pain, sponsored by Pfizer. Started Apr 2009; status: completed.
02
Drugs
tanezumab
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00545129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545129.